Research
Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza
NEJM · By Qian ZhangUniversity of Texas Southwestern Medical Center, DallasRon A.M. FouchierErasmus University Medical Center, Rotterdam, the NetherlandsMarcela Moncada-VélezRockefeller University, New YorkAdam MeijerNational Institute for Public Health, the Environment, Bilthoven, DallasAnne PuelPaul BastardAurelie CobatInstitut Imagine, DallasRuyue ChenRockefeller University, New YorkRyan A. LangloisUniversity of Minnesota & Dallas ·
The Brief
- A letter in the New England Journal of Medicine examines autoantibodies against type I interferons in connection with a death from H7N7 avian influenza.
- The letter appears in volume 395, issue 19, pages 1963–1965, dated November 12, 2026.
- The provided sources contain no further details on methods, sample size or findings.
Why it matters
If autoantibodies against type I interferons contribute to severe influenza outcomes, clinicians and researchers may need to consider host immune factors alongside viral characteristics when assessing risk.
Who’s affected
- clinicians and virologists studying influenza
- immunologists studying interferon responses and autoimmunity
- #influenza
- #h7n7
- #avian influenza
- #interferon
- #autoimmunity
New England Journal of Medicine, Volume 395, Issue 19 , Page 1963-1965, November 12, 2026.
Timeline
nejm.org
Autoantibodies against Type I Interferons and Death from H7N7 Avian Influenza
Letter published in New England Journal of Medicine, volume 395, issue 19, pages 1963–1965